The treatment fee of Chinese crown disease patients will be included in the medical in

The joint issuance of the four departments of China clearly states that the hospitalization fee and emergency treatment expenses of Chinese crown diseases will be included in the medical insurance. It will be implemented from the official burden and will be implemented until March 31 this year.

According to surging news reports, the National Medical Insurance Bureau, the Ministry of Finance, the National Health and Health Commission, and the State CDC issued a new type of coronary virus after the implementation of the "Class B and B" after the implementation of the "Class B and B"Notice of the treatment of medical protection for treatment costs in infection.

The notification requires that the patients with crown diseases occur in all medical institutions in cure for the treatment of coronary disease diagnosis and treatment plans formulated by the health and health department.After the rescue is paid in accordance with the regulations, the personal burden will be provided by the finance. The required funds shall be paid by the local finance first, and the central government will be subsidized at 60%of the actual costs.The policy is calculated based on the admission time of patients and performed first until March 31, 2023.

The notice also mentioned that encouraging grass -roots medical institutions with coronary treatment drugs in the medical insurance and drug catalog (including temporary supplementation of various provinces), and the occurrence of insured patients in designated medical institutions at the grassroots levelIn principle, the outpatient consultation costs are not set up and the ceiling line is not set up, and the reimbursement ratio is not less than 70%.

The notification is clear, the crown disease treatment drugs in the crown disease diagnosis and treatment plan continues the temporary medical insurance payment policy, and will be implemented until March 31 this year.If some places are considered to expand the medical insurance and drug catalogs temporarily due to insufficient drug supply, they can refer to the category of crown disease treatment drugs identified by the provincial joint prevention and control mechanism.The category and reimbursement category will be reported to the State Medical Insurance Administration for record.